Equity Overview
Price & Market Data
Price: $4.95
Daily Change: $0.00 / 0.00%
Daily Range: $4.31 - $5.02
Market Cap: $164,620,112
Daily Volume: 443,884
Performance Metrics
1 Week: 3.56%
1 Month: -38.43%
3 Months: -35.80%
6 Months: -31.72%
1 Year: -20.67%
YTD: -35.80%
Company Details
Employees: 58
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also provides Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Emrosi for the treatment of inflammatory lesions of rosacea; Exelderm cream and solution for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.